Researcher

Rui Guo

Chinese Academy of Medical Sciences & Peking Union Medical College

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 3, 2026 · JOURNAL ARTICLE

Comparative epidemiology of six respiratory pathogens among children aged 28 days to 14 years with acute respiratory infections in coastal Xiamen and inland Linxia, China: a multicenter retrospective study

Frontiers in Public Health

Retrospective descriptive epidemiology from a single calendar year with no clinical outcomes, control group, or intervention; establishes pathogen prevalence patterns but cannot determine causation, severity, or practice-relevant associations.

PreliminaryJumei Liu Xingxiang Zheng Jiali Cao

Reported

Sample size5835

Overall positivity53.9%

Co-detections5.0%

AUG 13, 2026 · JOURNAL ARTICLE

MMP14-engineered biomimetic nanodrug for intratumoral antibacterial therapy suppresses colorectal cancer growth and liver metastasis

Journal of Nanobiotechnology

Early-stage preclinical study demonstrating proof-of-concept for a novel nanodrug in mouse models of colorectal cancer; no human efficacy data, clinical outcomes, or comparative efficacy trial provided.

PreliminaryQianyi Ming Rui Guo Zhiwen Lin

Reported

Primary outcome measureSubcutaneous tumor growth and liver metasta…

Immune response markerEnhanced CD8+ T-cell infiltration

Bacterial burdenDecreased intratumoral Fn signals